About this trial
Clinical Characteristics, Etiology, Short-Term Outcomes, and Performance of Contemporary Risk Stratification Scores in Acute Heart Failure Patients Presenting to Assiut University Heart Hospital.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age more than 18yrs
Clinical diagnosis of acute heart failure according to current ESC guideline criteria.
Disqualifiers
Age below than 18
Refusal to participate.
Trial population
Acute heart failure patients presenting to Emergency Department and Cardiology Department, Assiut University Hospitals, Egypt.
Trial design
Other
Prospective
Treatments tested in this trial
Echo
Diagnostic testEcho for clinical assessment
Ecg
Diagnostic testTwelve leads ECG to detect any ischemic changes
Creatinine
Diagnostic testTo detect renal function test
Troponin
Diagnostic testIschemic changes
Treatment groups
Trial outcomes
Primary outcomes
Clinical Characteristics, Etiology, Short-Term Outcomes, and Performance of Contemporary Risk Stratification Scores in Acute Heart Failure Patients Presenting to Assiut University Heart Hospital.
To externally validate the HEARTRISK6 score and evaluate its predictive performance for short-term adverse outcomes in patients with acute heart failure. History of moderate/severe valvular heart disease\_Yes. 1 Heart rate \>100 to ≤120 bpm. 2 \>120 bpm. 3 Non-invasive ventilation (NIV)BiPAP/NIV within first hour 2 Creatinine \>150 to ≤300 µmol/L 2 \>300 µmol/L. 3 Troponin \>3-5 × upper reference limit (URL) 1 \>5 × URL. 2 Failed reassessment / 3-minute walk test ifFailed1 comp0 High score means worse
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: